253 related articles for article (PubMed ID: 2581581)
1. Effects of intraventricular injections of 6-hydroxydopamine on amine metabolites in rat brain and urine.
Edwards DJ; Ravitch J; Knopf S; Sedlock ML
Biochem Pharmacol; 1985 Apr; 34(8):1255-63. PubMed ID: 2581581
[TBL] [Abstract][Full Text] [Related]
2. Effects of debrisoquin on the excretion of catecholamine and octopamine metabolites in the rat and guinea pig.
Edwards DJ; Ravitch J; Knopf S
Biochem Pharmacol; 1985 Aug; 34(16):2911-6. PubMed ID: 3896245
[TBL] [Abstract][Full Text] [Related]
3. 6-Hydroxydopamine lesions of dopaminergic A10 neurons. Long-term effects on the urinary excretion of free and conjugated catecholamines and their metabolites in the rat.
Peyrin L; Simon H; Cottet-Emard JM; Bruneau N; Le Moal M
Brain Res; 1982 Mar; 235(2):363-9. PubMed ID: 6821353
[TBL] [Abstract][Full Text] [Related]
4. Dopamine metabolites in rat cisternal cerebrospinal fluid: major contribution from extrastriatal dopamine neurones.
Hutson PH; Curzon G
J Neurochem; 1986 Jan; 46(1):186-90. PubMed ID: 2415677
[TBL] [Abstract][Full Text] [Related]
5. Brain concentrations of biogenic amine metabolites in acutely treated and ethanol-dependent rats.
Karoum F; Wyatt RJ; Majchrowicz E
Br J Pharmacol; 1976 Apr; 56(4):403-11. PubMed ID: 769883
[TBL] [Abstract][Full Text] [Related]
6. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
[TBL] [Abstract][Full Text] [Related]
7. Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism.
Karoum F; Suddath RL; Wyatt RJ
Eur J Pharmacol; 1990 Sep; 186(1):1-8. PubMed ID: 2282931
[TBL] [Abstract][Full Text] [Related]
8. The effect of dietary precursors on the excretion of amines and their metabolites in the rat.
Sedlock ML; Ravitch J; Edwards DJ
Biochem Med; 1985 Dec; 34(3):318-26. PubMed ID: 3938280
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute administration of cyclazocine on the metabolism of biogenic amines in different regions of rat brain.
Gavend MM; Serre F; Gavend MR; Ragoucy C; Caron P
Psychopharmacology (Berl); 1981; 75(1):79-83. PubMed ID: 6171003
[TBL] [Abstract][Full Text] [Related]
10. Effect of selective destruction of central and peripheral catecholamine-containing neurones with 6-hydroxydopamine on catecholamine excretion in the rat.
Hoeldtke R; Rogawski M; Wurtman RJ
Br J Pharmacol; 1974 Feb; 50(2):265-70. PubMed ID: 4425765
[TBL] [Abstract][Full Text] [Related]
11. Prenatal effects of acute harmaline exposure on fetal brain biogenic amine metabolism.
Okonmah AD; Brown JW; Blyden GT; Soliman KF
Pharmacology; 1988; 37(3):203-8. PubMed ID: 2465555
[TBL] [Abstract][Full Text] [Related]
12. A new approach to biochemical evaluation of brain dopamine metabolism.
Kopin IJ; White JH; Bankiewicz K
Cell Mol Neurobiol; 1988 Jun; 8(2):171-9. PubMed ID: 3044592
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycol-sulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain.
Nielsen M; Braestrup C
Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):87-92. PubMed ID: 593430
[No Abstract] [Full Text] [Related]
14. 6-Hydroxydopamine and 5,7-dihydroxytryptamine selectively reduce dopamine and 5-hydroxytryptamine metabolites in cerebroventricular perfusates of rats.
Nielsen JA; Moore KE
Pharmacol Biochem Behav; 1983 Nov; 19(5):905-7. PubMed ID: 6417682
[TBL] [Abstract][Full Text] [Related]
15. Effect of probenecid on endogenous and exogenous 3,4-dihydroxyphenylacetic acid and homovanillic acid in the rat brain.
Broch OJ
Eur J Pharmacol; 1976 Sep; 39(1):33-40. PubMed ID: 964303
[TBL] [Abstract][Full Text] [Related]
16. Free and conjugated 3,4-dihydroxyphenylacetic acid and homovanillic acid in brain dopaminergic areas at basal state and after pipotiazine activation.
Tavitian E; Peyrin L; Dalmaz Y; Favre R; De Haut M; Cottet-Emard JM
J Neural Transm; 1986; 65(3-4):261-75. PubMed ID: 2872271
[TBL] [Abstract][Full Text] [Related]
17. Association between the levels of biogenic amines and superoxide anion production in brain regions of rats after subchronic exposure to TCDD.
Byers JP; Masters K; Sarver JG; Hassoun EA
Toxicology; 2006 Dec; 228(2-3):291-8. PubMed ID: 17070641
[TBL] [Abstract][Full Text] [Related]
18. Changes of serotonin and catecholamines are related to pharmacokinetic alterations of clomipramine in rat brain.
Fujita K; Kobayashi A; Suzuki S; Nakazawa K
Eur J Pharmacol; 1991 Nov; 204(3):227-33. PubMed ID: 1723048
[TBL] [Abstract][Full Text] [Related]
19. Conversion of 3, 4-dihydroxyphenylalanine and deuterated 3, 4-dihydroxyphenylalanine to alcoholic metabolites of catecholamines in rat brain.
Edwards DJ; Rizk M
J Neurochem; 1981 May; 36(5):1641-7. PubMed ID: 6165806
[TBL] [Abstract][Full Text] [Related]
20. Androgen inhibits neurotransmitter turnover in the medial prefrontal cortex of the rat following exposure to a novel environment.
Handa RJ; Hejna GM; Lorens SA
Brain Res; 1997 Mar; 751(1):131-8. PubMed ID: 9098576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
